Biosimilars de denosumab: accelerant el desenvolupament de fàrmacs per a inhibidors de RANKL
Denosumab represents one of the leading biologics applied today [...]
Denosumab represents one of the leading biologics applied today [...]
La liraglutida i la semaglutida s'han convertit en actors clau [...]